mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27

20Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Glioma has become a significant global health problem with substantial morbidity and mortality, underscoring the importance of elucidating its underlying molecular mechanisms. Recent studies have identified mir-218 as an anti-oncogene; however, the specific functions of mir-218-1 and mir-218-2 remain unknown, especially the latter. The objective of this study was to further investigate the role of mir-218-2 in glioma. Our results indicated that mir-218-2 is highly overexpressed in glioma. Furthermore, we showed that mir-218-2 is positively correlated with the growth, invasion, migration, and drug susceptibility (to β-lapachone) of glioma cells. In vitro, the overexpression of mir-218-2 promoted glioma cell proliferation, invasion, and migration. In addition, the overexpression of mir-218-2 in vivo was found to increase glioma tumor growth. Accordingly, the inhibition of mir-218-2 resulted in the opposite effects. Cell division cycle 27 (CDC27), the downstream target of mir- 218-2, is involved in the regulation of glioma cells. Our results indicate that the overexpression of CDC27 counteracted the function of mir-218-2 in glioma cells. These novel findings provide new insight in the application of mir-218-2 as a potential glioma treatment.

References Powered by Scopus

CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010

1456Citations
N/AReaders
Get full text

A systematic review of MicroRNA in glioblastoma multiforme: Micro-modulators in the mesenchymal mode of migration and invasion

236Citations
N/AReaders
Get full text

MicroRNA-218 inhibits glioma invasion, migration, proliferation, and Cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1

214Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer

49Citations
N/AReaders
Get full text

MicroRNA-218 promotes cisplatin resistance in oral cancer via the PPP2R5A/Wnt signaling pathway

42Citations
N/AReaders
Get full text

JSRC: A flexible and accurate joint learning algorithm for clustering of single-cell RNA-sequencing data

38Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Feng, Z., Zhang, L., Zhou, J., Zhou, S., Li, L., Guo, X., … Huang, F. (2017). mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27. Oncotarget, 8(4), 6304–6318. https://doi.org/10.18632/oncotarget.13850

Readers over time

‘18‘19‘20‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

44%

Researcher 4

44%

Professor / Associate Prof. 1

11%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 8

73%

Medicine and Dentistry 3

27%

Save time finding and organizing research with Mendeley

Sign up for free
0